Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
ROE: Strong Returns
Above historical average.
Left:
||||
Return on equity
Latest
-54.77%
↑ 55% above average
Average (9y)
-121.11%
Historical baseline
Range
High:-15.06%
Low:-382.83%
CAGR
-0.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -54.77% | +7.8% |
| 2023 | -59.42% | -63.3% |
| 2022 | -36.40% | -80.6% |
| 2021 | -20.15% | -33.7% |
| 2020 | -15.06% | +93.3% |
| 2019 | -224.50% | -37.5% |
| 2018 | -163.24% | +57.4% |
| 2017 | -382.83% | -93.0% |
| 2016 | -198.32% | -251.6% |
| 2015 | -56.41% | - |